Abstract
The present disclosure relates to compounds which bind Ca2+/calmodulin dependent protein kinase II. It also relates to such compounds for use in the treatment of CNS disorders with sleep disturbances and acute brain injury.
Original language | English |
---|---|
IPC | A61K31/4164,A61K31/4178,A61P25/00,C07D277/06,C07D277/12,C07D277/56,C07D417/04,C07D417/10 |
Patent number | WO2023170024A1 |
Filing date | 01/01/1970 |
Country/Territory | United States |
Priority number | US202263318852P |
Publication status | Published - 2023 |